The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background
暂无分享,去创建一个
Sharon Marsh | S. Marsh | Junbo Hu | Chaodong Wu | Jinsheng Yu | W. Feng | Junbo Hu | Jinsheng Yu | Wenke Feng | Chaodong Wu | Wenke Feng
[1] P. Brun,et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[2] Greger Lindberg,et al. Decreased survival of subjects with elevated liver function tests during a 28‐year follow‐up , 2010, Hepatology.
[3] A. Suzuki,et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease , 2010, Hepatology.
[4] L. Velloso,et al. Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet. , 2007, The Journal of endocrinology.
[5] L. Adorini,et al. Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease* , 2013, The Journal of Biological Chemistry.
[6] C. McClain,et al. Fructose Induced Endotoxemia in Pediatric Nonalcoholic Fatty Liver Disease , 2014, International journal of hepatology.
[7] Jamey D. Young,et al. Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. , 2013, Progress in lipid research.
[8] F. Bellanti,et al. Alterations of hepatic ATP homeostasis and respiratory chain during development of non‐alcoholic steatohepatitis in a rodent model , 2008, European journal of clinical investigation.
[9] H. Tilg. The Role of Cytokines in Non-Alcoholic Fatty Liver Disease , 2010, Digestive Diseases.
[10] C. Kahn,et al. Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome. , 2015, Cell metabolism.
[11] Lixin Zhu,et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH , 2013, Hepatology.
[12] R. Kreis,et al. Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans , 2013, Obesity.
[13] Franca Fagioli,et al. Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. , 2011, Journal of hepatology.
[14] Tutut Herawan,et al. Computational and mathematical methods in medicine. , 2006, Computational and mathematical methods in medicine.
[15] H. Tilg,et al. Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis , 2010, Hepatology.
[16] C. McClain,et al. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. , 2015, Clinical biochemistry.
[17] M. Kleerebezem,et al. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. , 2012, American journal of physiology. Gastrointestinal and liver physiology.
[18] J. Stockman,et al. Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5 , 2012 .
[19] D. Schuppan,et al. Non‐alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches , 2013, Journal of gastroenterology and hepatology.
[20] M. Pagliassotti,et al. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. , 2006, Endocrinology.
[21] S. Kliewer,et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.
[22] G. La Torre,et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease , 2009, Hepatology.
[23] C. Rogenstein,et al. Dietary and physical activity patterns in children with fatty liver , 2010, European Journal of Clinical Nutrition.
[24] Dermot F. Reilly,et al. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent. , 2016, Gastroenterology.
[25] C. Day. Non-alcoholic fatty liver disease: current concepts and management strategies. , 2006, Clinical medicine.
[26] F. Bäckhed,et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. , 2013, Cell metabolism.
[27] L. Glimcher,et al. Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.
[28] A. Diehl,et al. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis , 2001, American Journal of Gastroenterology.
[29] R. DeFronzo,et al. Non-Alcoholic Fatty Liver Disease (NAFLD) and Its Connection with Insulin Resistance, Dyslipidemia, Atherosclerosis and Coronary Heart Disease , 2013, Nutrients.
[30] J. Nicholson,et al. Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. , 2014, Gastroenterology.
[31] M. Orho-Melander,et al. Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2. , 2015, Journal of hepatology.
[32] P. Angulo. Long‐term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance? , 2010, Hepatology.
[33] F. Bäckhed,et al. Obesity alters gut microbial ecology. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Antoun,et al. Hepatic TLR4 signaling in obese NAFLD. , 2015, American journal of physiology. Gastrointestinal and liver physiology.
[35] S. Lang,et al. Nonalcoholic fatty liver disease – current status and future directions , 2015, Journal of digestive diseases.
[36] E. Elinav,et al. NLRP6 Inflammasome Orchestrates the Colonic Host-Microbial Interface by Regulating Goblet Cell Mucus Secretion , 2014, Cell.
[37] Barbara M. Bakker,et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.
[38] A. Sanyal,et al. Lipotoxicity in NASH. , 2012, Journal of hepatology.
[39] P. Lampertico,et al. Patatin‐like phospholipase domain‐containing 3 I148M affects liver steatosis in patients with chronic hepatitis B , 2013, Hepatology.
[40] D. Albanes,et al. PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity. , 2015, The Journal of nutrition.
[41] E. Parks,et al. Dietary sugars stimulate fatty acid synthesis in adults. , 2008, The Journal of nutrition.
[42] M. McCarthy,et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.
[43] C. Stokes,et al. HCC and liver disease risks in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance. , 2015, Journal of hepatology.
[44] D. Russell. The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.
[45] E. Vanni,et al. PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non‐obese subjects with hepatitis C , 2015, Alimentary pharmacology & therapeutics.
[46] S. McCall,et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. , 2008, Journal of hepatology.
[47] L. Makowski,et al. The inflammation highway: metabolism accelerates inflammatory traffic in obesity , 2012, Immunological reviews.
[48] E. Paschetta,et al. TM6SF2 may drive postprandial lipoprotein cholesterol toxicity away from the vessel walls to the liver in NAFLD. , 2016, Journal of hepatology.
[49] D. Jenden,et al. Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation , 1995, Hepatology.
[50] L. N. Valenti,et al. Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant. , 2015, The Journal of clinical endocrinology and metabolism.
[51] S. Baker,et al. Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis , 2014, Journal of gastroenterology and hepatology.
[52] N. Kapel,et al. Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease. , 2016, Clinical nutrition.
[53] Amalia Gastaldelli,et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. , 2007, Gastroenterology.
[54] C. McClain,et al. The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease. , 2012, Alcoholism, clinical and experimental research.
[55] Dong Wang,et al. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. , 2006, American journal of physiology. Endocrinology and metabolism.
[56] A. Fodor,et al. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. , 2011, Gastroenterology.
[57] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[58] C. Chai,et al. Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats , 2013, Nutrition & Metabolism.
[59] W. An,et al. Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance , 2011, Journal of Molecular Medicine.
[60] L. Szweda,et al. Modulation of mitochondrial complex I activity by reversible Ca2+ and NADH mediated superoxide anion dependent inhibition. , 2004, Biochemistry.
[61] S. Bischoff,et al. Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model. , 2013, The Journal of nutritional biochemistry.
[62] Richard A. Flavell,et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.
[63] J. Borén,et al. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease , 2015, Hepatology.
[64] Barbara M. Bakker,et al. Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation , 2015, Diabetes.
[65] Q. Anstee,et al. The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2 , 2015, Seminars in Liver Disease.
[66] M. van der Graaf,et al. Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia , 2011, Diabetologia.
[67] T. D. Pugh,et al. Mitochondrial DNA Mutations, Oxidative Stress, and Apoptosis in Mammalian Aging , 2005, Science.
[68] C. Hetz. The unfolded protein response: controlling cell fate decisions under ER stress and beyond , 2012, Nature Reviews Molecular Cell Biology.
[69] F. Schick,et al. Dissociation Between Fatty Liver and Insulin Resistance in Humans Carrying a Variant of the Patatin-Like Phospholipase 3 Gene , 2009, Diabetes.
[70] Anne Tybjærg-Hansen,et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease , 2014, Nature Genetics.
[71] H. Tilg,et al. Inflammatory Mechanisms in the Regulation of Insulin Resistance , 2008, Molecular medicine.
[72] S. Sookoian,et al. Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease , 2011, Hepatology.
[73] P. Ravasco,et al. Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet , 2008, Scandinavian journal of gastroenterology.
[74] J. Hardies,et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease , 2012, Hepatology.
[75] Xi Jin,et al. HDMCP uncouples yeast mitochondrial respiration and alleviates steatosis in L02 and hepG2 cells by decreasing ATP and H2O2 levels: a novel mechanism for NAFLD. , 2009, Journal of hepatology.
[76] M. Ronis,et al. Dietary saturated fat reduces alcoholic hepatotoxicity in rats by altering fatty acid metabolism and membrane composition. , 2004, The Journal of nutrition.
[77] M. Hellerstein,et al. A dual sugar challenge test for lipogenic sensitivity to dietary fructose. , 2011, The Journal of clinical endocrinology and metabolism.
[78] U. Ozcan,et al. Unfolded Protein Response Signaling and Metabolic Diseases* , 2013, The Journal of Biological Chemistry.
[79] J. Schattenberg,et al. Insulin resistance alters hepatic ethanol metabolism: studies in mice and children with non-alcoholic fatty liver disease , 2015, Gut.
[80] P. Walter,et al. Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.
[81] K. Clément,et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease , 2014, Nature Communications.
[82] L. Beilin,et al. Lower Fructose Intake May Help Protect Against Development of Nonalcoholic Fatty Liver in Adolescents With Obesity , 2014, Journal of pediatric gastroenterology and nutrition.
[83] Ruslan Medzhitov,et al. Toll-like receptors and innate immunity , 2001, Nature Reviews Immunology.
[84] S. Petta,et al. Genetic background in nonalcoholic fatty liver disease: A comprehensive review. , 2015, World journal of gastroenterology.
[85] Dae-Joong Kang,et al. Bile salt biotransformations by human intestinal bacteria Published, JLR Papers in Press, November 18, 2005. , 2006, Journal of Lipid Research.
[86] G. Hotamisligil,et al. Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.
[87] G. Bánhegyi,et al. Lipotoxicity in the liver. , 2013, World journal of hepatology.
[88] G. Musso,et al. Emerging Liver-Kidney Interactions in Nonalcoholic Fatty Liver Disease. , 2015, Trends in molecular medicine.
[89] Q. Anstee,et al. The genetics of NAFLD , 2013, Nature Reviews Gastroenterology &Hepatology.
[90] D. Pessayre,et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. , 1998, Gastroenterology.
[91] Jie Yu,et al. Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis , 2015, PloS one.
[92] B. Motta,et al. Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function. , 2014, Biochimica et biophysica acta.
[93] Christoph Handschin,et al. Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP , 2005, Cell.
[94] M. McCarthy,et al. Paradoxical Lower Serum Triglyceride Levels and Higher Type 2 Diabetes Mellitus Susceptibility in Obese Individuals with the PNPLA3 148M Variant , 2012, PloS one.
[95] M. Karin,et al. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates , 2006, Proceedings of the National Academy of Sciences.
[96] S. Bischoff,et al. Lactobacillus rhamnosus GG Protects against Non-Alcoholic Fatty Liver Disease in Mice , 2014, PloS one.
[97] Yanqiao Zhang,et al. Bile acid receptors in non-alcoholic fatty liver disease. , 2013, Biochemical pharmacology.
[98] A. Schwiertz,et al. Microbiota and SCFA in Lean and Overweight Healthy Subjects , 2010, Obesity.
[99] P. Turnbaugh,et al. Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.
[100] J. Browning,et al. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. , 2014, Gastroenterology.
[101] M. Wilkinson,et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples , 1995, Applied and environmental microbiology.
[102] P. Puri,et al. Mechanisms of simple hepatic steatosis: not so simple after all. , 2012, Clinics in liver disease.
[103] Z. Halpern,et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. , 2007, Journal of hepatology.
[104] J. Dufour,et al. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma. , 2014, Journal of hepatology.
[105] C. Day. Pathogenesis of steatohepatitis. , 2002, Best practice & research. Clinical gastroenterology.
[106] E. Quigley,et al. The role of the gut microbiota in nonalcoholic fatty liver disease , 2010, Nature Reviews Gastroenterology &Hepatology.
[107] S. Bischoff,et al. Toll-like receptors 1-9 are elevated in livers with fructose-induced hepatic steatosis. , 2012, The British journal of nutrition.
[108] L. N. Valenti,et al. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells , 2014, Human molecular genetics.
[109] M. Arrese,et al. Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. , 2015, Biochimica et biophysica acta.
[110] N. Nowak,et al. Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis , 2010, PloS one.
[111] C. Day,et al. Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.
[112] Alexander Pertsemlidis,et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.
[113] A. Bast,et al. The role of oxidative stress in non-alcoholic steatohepatitis. , 2011, Clinica chimica acta; international journal of clinical chemistry.
[114] M. Trauner,et al. Bile acid receptors as targets for drug development , 2014, Nature Reviews Gastroenterology &Hepatology.
[115] N. Lundbom,et al. Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans. , 2011, The American journal of clinical nutrition.
[116] Josivan G. Lima,et al. Is nonalcoholic fatty liver disease an endogenous alcoholic fatty liver disease? - A mechanistic hypothesis. , 2015 .
[117] D. Artis. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut , 2008, Nature Reviews Immunology.
[118] A. Nanji,et al. Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. , 2001, The Journal of pharmacology and experimental therapeutics.
[119] Wei Zhang,et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. , 2009, The Journal of clinical investigation.
[120] K. Schechtman,et al. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. , 2010, Gastroenterology.
[121] E. Brunt,et al. Nonalcoholic fatty liver disease: pathology and pathogenesis. , 2010, Annual review of pathology.
[122] S. Rabot,et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice , 2012, Gut.
[123] J. Borén,et al. PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[124] K. Nelson,et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. , 2015, Gastroenterology.
[125] PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells , 2014, Human molecular genetics.
[126] F. Schick,et al. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans. , 2009, Clinical science.
[127] J. Carvalheira,et al. Loss-of-Function Mutation in Toll-Like Receptor 4 Prevents Diet-Induced Obesity and Insulin Resistance , 2007, Diabetes.
[128] W. Nseir,et al. Soft drink consumption linked with fatty liver in the absence of traditional risk factors. , 2008, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[129] T. Saibara,et al. Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese , 2012, PloS one.
[130] S. Akira,et al. Toll-like receptors and innate immunity , 2006, Journal of Molecular Medicine.
[131] D. Wasserman,et al. Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver , 2013, Molecular and Cellular Endocrinology.
[132] F. Lammert,et al. PNPLA3-Associated Steatohepatitis: Toward a Gene-Based Classification of Fatty Liver Disease , 2013, Seminars in Liver Disease.
[133] G. Gores,et al. Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis* , 2006, Journal of Biological Chemistry.
[134] D. Pessayre. Role of mitochondria in non‐alcoholic fatty liver disease , 2007, Journal of gastroenterology and hepatology.
[135] C. Xing,et al. Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population , 2012, BMC Medical Genetics.
[136] M. Laville,et al. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. , 2011, The Journal of nutritional biochemistry.
[137] G. Pacini,et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association , 2002, Hepatology.
[138] Nick V. Grishin,et al. A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis , 2009, The Journal of Biological Chemistry.
[139] B. Fielding,et al. The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease , 2014, Nutrients.
[140] Jin-Wook Kim,et al. Role of the PNPLA3 I148M Polymorphism in Nonalcoholic Fatty Liver Disease and Fibrosis in Korea , 2014, Digestive Diseases and Sciences.
[141] M. Clemens,et al. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[142] T. Risby,et al. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. , 2000, Gastroenterology.
[143] J. Kruk,et al. Occurrence, biosynthesis and function of isoprenoid quinones. , 2010, Biochimica et biophysica acta.
[144] J. Clore,et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.
[145] N. Lundbom,et al. Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity. , 2011, Journal of hepatology.